- Home
- CNTB vs KNDI Comparison
CNTB vs KNDI Comparison
Compare CNTB & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- KNDI
- Stock Information
- Founded
- CNTB 2012
- KNDI 2002
- Country
- CNTB United States
- KNDI China
- Employees
- CNTB N/A
- KNDI N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- KNDI Auto Manufacturing
- Sector
- CNTB Health Care
- KNDI Consumer Discretionary
- Exchange
- CNTB Nasdaq
- KNDI Nasdaq
- Market Cap
- CNTB 94.2M
- KNDI 101.7M
- IPO Year
- CNTB 2021
- KNDI N/A
- Fundamental
- Price
- CNTB $1.59
- KNDI $1.19
- Analyst Decision
- CNTB Strong Buy
- KNDI
- Analyst Count
- CNTB 2
- KNDI 0
- Target Price
- CNTB $7.50
- KNDI N/A
- AVG Volume (30 Days)
- CNTB 79.5K
- KNDI 111.5K
- Earning Date
- CNTB 11-30-2025
- KNDI 11-17-2025
- Dividend Yield
- CNTB N/A
- KNDI N/A
- EPS Growth
- CNTB N/A
- KNDI N/A
- EPS
- CNTB N/A
- KNDI N/A
- Revenue
- CNTB $1,965,000.00
- KNDI $104,035,613.00
- Revenue This Year
- CNTB N/A
- KNDI N/A
- Revenue Next Year
- CNTB $453,067.90
- KNDI N/A
- P/E Ratio
- CNTB N/A
- KNDI N/A
- Revenue Growth
- CNTB N/A
- KNDI N/A
- 52 Week Low
- CNTB $1.23
- KNDI $0.89
- 52 Week High
- CNTB $2.20
- KNDI $1.81
- Technical
- Relative Strength Index (RSI)
- CNTB 45.14
- KNDI 39.24
- Support Level
- CNTB $1.50
- KNDI $1.16
- Resistance Level
- CNTB $1.72
- KNDI $1.29
- Average True Range (ATR)
- CNTB 0.13
- KNDI 0.06
- MACD
- CNTB -0.02
- KNDI -0.00
- Stochastic Oscillator
- CNTB 18.00
- KNDI 10.53
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.